David Watson is the Executive Director, Patient Access.

David was previously the ABPI Commercial Policy Director leading on the Voluntary Scheme.

David joined the ABPI in May 2014 from a consulting background and prior to that spent many years at Pfizer where he held a series of roles including European Head of Business Intelligence, channel strategy, and a variety of sales and marketing positions in the UK and the Pfizer European business.